10:28 AM, 25th Apr 2025
Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2025 inter alia to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31 2025 and recommendation of dividend if any for the financial year ended March 31 2025.